申请人:——
公开号:US20030105073A1
公开(公告)日:2003-06-05
Quinolone derivatives of formula (1) are described:
1
wherein:
X is an O or S atom;
R
1
is an aliphatic, cycloaliphatic, or cycloalkyl-alkyl-group;
R
2
is a —CN group or an optionally substituted heteroaromatic group;
R
3
is a hydrogen atom or an alkyl, —CN, —CO
2
H, —CO
2
R
6
or —CONR
7
R
8
group;
R
4
is a chain -Alk
1
-L
1
-Alk
2
-R
9
;
R
5
is a hydrogen atom or an alkyl group;
or NR
4
R
5
forms an optionally substituted heterocycloaliphatic ring optionally fused to an optionally substituted monocyclic C
6-12
aromatic group or an optionally substituted monocyclic C
1-9
heteroaromatic group; and the salts, solvates, hydrates, tautomers, isomers or N-oxides thereof.
The compounds are potent inhibitors of IMPDH and are of use as immunosuppressants, anti-cancer agents, anti-inflammatory agents, antipsoriatic and anti-viral agents.
描述了式(1)的喹诺酮衍生物:1其中:X是O或S原子;R1是脂肪族、环脂族或环烷基-烷基基团;R2是-CN基团或可选取代的杂芳基基团;R3是氢原子或烷基、-CN、-CO2H、-CO2R6或-CONR7R8基团;R4是链状-Alk1-L1-Alk2-R9;R5是氢原子或烷基;或NR4R5形成可选取代的杂环脂族环,可选择地融合到可选取代的单环C6-12芳香基团或可选取代的单环C1-9杂芳基团上;以及它们的盐、溶剂化物、水合物、互变异构体、同分异构体或N-氧化物。这些化合物是IMPDH的强效抑制剂,可用作免疫抑制剂、抗癌剂、抗炎剂、抗牛皮癣剂和抗病毒剂。